Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,592.40
(
0.20%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
94.59
(
-1.44%
)
Bitcoin
71,084.13
(
-0.40%
)
News Focus
News Focus
Post# of 57998
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

K-G

Send PM Follow Ignore
Followers 4
Posts 153
Boards Moderated 0
Alias Born 10/25/2006

K-G

Re: Market_Fest4 post# 17141

Wednesday, 05/14/2008 10:03:33 PM

Wednesday, May 14, 2008 10:03:33 PM

Post# of 57998
The University of Alberta apparantly holds or has applied for a patent for the use of ampakines in treating respiratory depression. (I tried to search the US Patent and Trade Mark data base, but could not find it. Maybe someone else can.) Cortex in-licensed the rights to their use patent. The referenced article for respiratory depresson is at the link below.

http://ajrccm.atsjournals.org/cgi/content/full/174/12/1384
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today